Metall Zug AG (METN) AI Stock Analysis

• Market Cap: $468.44M
• Dividend Yield: 1.91%
• Average Volume (3M): 247.00
• Price to Earnings (P/E): 8.9
• Beta (1Y): 0.58
• Revenue Growth: -42.71%
• EPS Growth: N/A
• Country: CH
• Employees: 983
• Sector: Industrials
• Sector Strength: 84
• Industry: Conglomerates
• EPS (TTM): 116.87
• Shares Outstanding: 255,136
• 10 Day Avg. Volume: 179
• 30 Day Avg. Volume: 247
• PEG Ratio: 0.03
• Price to Book (P/B): 1.09
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -22.93
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $1,072.48
• Price Target Upside: 2.14% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 64 Neutral
• Price Target: CHF1,124.00 ▲(7.05%Upside)

The overall score reflects stable technical indicators and attractive valuation, offset by challenges in financial performance, particularly in cash flow management. The company's stable balance sheet supports its long-term financial health, but improvements in revenue growth and cash generation are necessary for a better outlook.

Metall Zug AG Business Overview & Revenue Model

Company Description

Metall Zug AG, through its subsidiaries, engages in the wire processing, medical devices, infection control, technologycluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. The company's Wire Processing business unit develops, produces, and distributes semiautomatic and fully automatic machines for cutting and stripping, crimping, sealing, twisting, tinning, printing, quality control, and process and test automation for various wires and cables. This segment also offers software packages for optimizing machine efficiency and utilization for complex applications and connection of data. Its Medical Devices business unit develops, produces, and distributes diagnosis and microsurgery products primarily in the fields of ophthalmology, as well as covers applications in the fields of pulmonology and measuring instruments. This business unit offers diagnostics products, including slit lamps, biometry, perimetry, tonometer, and practice management software for clinics and opticians, as well as practice equipment; and surgical products, such as microscopes, floor and roof stands, and accessories. The company's Infection Control business unit provides cleaning, disinfection, and sterilization solutions that are used in hospitals. Its Technologycluster & Infrastructure business unit engages in the management and development of real estate. The company's Others business unit offers cleaning, disinfection and sterilization systems and solutions primarily for use in the pharmaceutical industry; and professional appliances and integrated solutions, such as dishwasher and cooking technology, cleaning agents, and care systems for the hotel and catering industry, care homes, and hospitals. Metall Zug AG was founded in 1887 and is headquartered in Zug, Switzerland.

How the Company Makes Money

Metall Zug AG generates revenue through its portfolio of subsidiaries, each contributing to its overall financial performance. The company operates in distinct segments: medical devices, wire processing, and industrial solutions. In the medical devices sector, its subsidiary, Haag-Streit, specializes in ophthalmology and microsurgery equipment, selling these products to healthcare providers and institutions worldwide. The wire processing division, led by Schleuniger, offers cutting-edge machinery and solutions for wire cutting, stripping, and crimping, serving the automotive, information technology, and telecommunications industries. The industrial solutions segment includes Belimed, which provides sterilization solutions for hospitals and laboratories. Revenue is primarily derived from the sale of products and services, supported by long-term relationships with clients and a strong focus on innovation and quality assurance. Strategic partnerships and a global distribution network further bolster the company's revenue streams.

Metall Zug AG Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
447.48M	283.42M	494.71M	645.94M	661.89M	823.54M
	Gross Profit
132.73M	90.95M	151.65M	226.69M	228.21M	261.41M
	EBIT
58.15M	57.95M	13.75M	34.33M	20.67M	-2.18M
	EBITDA
76.13M	68.07M	43.12M	146.21M	57.62M	40.97M
	Net Income Common Stockholders
67.81M	52.59M	22.22M	129.98M	48.78M	14.31M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
380.93M	17.25M	29.80M	31.73M	81.84M	72.27M
	Total Assets
954.68M	632.95M	690.66M	701.19M	715.63M	635.24M
	Total Debt
31.32M	82.81M	36.60M	17.00M	4.17M	4.65M
	Net Debt
-100.07M	65.75M	7.03M	-14.43M	-77.38M	-67.11M
	Total Liabilities
262.73M	146.54M	168.84M	182.89M	199.44M	152.34M
	Stockholders Equity
691.96M	419.24M	455.51M	453.36M	450.94M	418.25M
Cash Flow		Free Cash Flow
-19.74M	-31.13M	-26.71M	-40.72M	14.27M	14.20M
	Operating Cash Flow
9.24M	2.77M	9.52M	-5.93M	48.98M	60.26M
	Investing Cash Flow
-31.05M	-53.54M	-16.41M	-41.81M	-32.35M	-63.23M
	Financing Cash Flow
19.56M	37.44M	6.89M	-17.63M	-8.21M	-76.13M

Metall Zug AG Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1050.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:METN, the sentiment is Positive. The current price of 1050 is above the 20-day moving average (MA) of 1045.25, above the 50-day MA of 1030.54, and below the 200-day MA of 1087.81, indicating a neutral trend. The MACD of 1.74 indicates Positive momentum. The RSI at 51.99 is Neutral, neither overbought nor oversold. The STOCH value of 34.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:METN.

Metall Zug AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	66 Neutral	$4.44B	12.08	5.34%	5.82%	4.17%	-11.81%
METN	64 Neutral	$468.44M	8.94	11.76%	1.91%	-42.71%	―
VETN	64 Neutral	CHF637.34M	93.05		3.11%	-6.31%	-78.36%
KOMN	57 Neutral	CHF505.56M	99.21		2.84%	-16.31%	-107.34%
RIEN	52 Neutral	CHF315.32M	30.29		2.32%	-39.44%	-85.89%
0QW1		CHF796.21M	486.72	-9.88%	0.85%	―	―
SCWTF		$685.58M	45.11	1.81%	3.83%	―	―

Metall Zug AG Corporate Events

Metall Zug AG Shareholders Approve Board Proposals and Sustainability Initiatives

At the 138th ordinary general meeting, Metall Zug AG’s shareholders approved all board proposals, including the election of Sandrine Zweifel to the board, a cash dividend distribution, and a contribution to the Greenhouse Gas Fund. These decisions align with the company’s strategic focus on sustainability and ophthalmology, potentially enhancing its industry positioning and stakeholder relations.

Metall Zug AG Reports Strong 2024 Financial Results Amid Strategic Advancements

Metall Zug AG reported a successful financial year 2024, marked by the profitable launch of the SteelcoBelimed joint venture and strategic advancements in ophthalmology. Despite a decline in net revenue due to divestments and market challenges, the company achieved a significant EBIT increase, driven by the merger profits and strategic investments. The company remains committed to its long-term growth strategy, focusing on innovation and infrastructure development, which is expected to enhance its market position and stakeholder value.